Mergers and Acquisitions

Merger agreement with Cephalon approved

Published in Biotech Business Week, July 12th, 2004

Cima Labs, Inc. (CIMA) announced that the stockholders of the company voted to approve the agreement and plan of merger between the company and Cephalon, Inc., (CEPH) at a special stockholders' meeting held in Bloomington, Minnesota.

The merger remains subject to approval by the Federal Trade Commission, which is currently reviewing the transaction.

Approximately 99.4% of stockholders present in person or by proxy voted in favor of the merger agreement. The number of shares voting to approve the Agreement and Plan of Merger represents approximately 71.3% of the outstanding shares entitled to vote.

On November 3, 2003, Cima and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2004-07-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry